Abstract
Animal studies are a foundation for defining mechanisms of atherosclerosis and potential targets of drugs to prevent lesion development or reverse the disease. In the current literature, it is common to see contradictions of outcomes in animal studies from different research groups, leading to the paucity of extrapolations of experimental findings into understanding the human disease. The purpose of this statement is to provide guidelines for development and execution of experimental design and interpretation in animal studies. Recommendations include the following: (1) animal model selection, with commentary on the fidelity of mimicking facets of the human disease; (2) experimental design and its impact on the interpretation of data; and (3) standard methods to enhance accuracy of measurements and characterization of atherosclerotic lesions.
Original language | English |
---|---|
Pages (from-to) | e53-e79 |
Journal | Circulation Research |
Volume | 121 |
Issue number | 6 |
DOIs | |
State | Published - Sep 1 2017 |
Bibliographical note
Publisher Copyright:© 2017 American Heart Association, Inc.
Funding
Funders | Funder number |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | R00HL116786 |
Keywords
- AHA Scientific Statements
- Animal models
- Atherosclerosis
- Cholesterol
- Histology
- Pathology
ASJC Scopus subject areas
- Physiology
- Cardiology and Cardiovascular Medicine